"Febrile Neutropenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fever accompanied by a significant reduction in the number of NEUTROPHILS.
| Descriptor ID |
D064147
|
| MeSH Number(s) |
C15.378.553.546.184.564.750
|
| Concept/Terms |
Febrile Neutropenia- Febrile Neutropenia
- Febrile Neutropenias
- Neutropenia, Febrile
- Neutropenias, Febrile
|
Below are MeSH descriptors whose meaning is more general than "Febrile Neutropenia".
Below are MeSH descriptors whose meaning is more specific than "Febrile Neutropenia".
This graph shows the total number of publications written about "Febrile Neutropenia" by people in this website by year, and whether "Febrile Neutropenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Febrile Neutropenia" by people in Profiles.
-
Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological Malignancies. Adv Ther. 2024 07; 41(7):2966-2977.
-
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial. Lancet Haematol. 2023 Jan; 10(1):e46-e58.
-
An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphoma. Int J Hematol. 2022 Mar; 115(3):391-398.
-
Oncologic emergencies in the emergency medicine residency curriculum: A national survey. Am J Emerg Med. 2020 11; 38(11):2477-2481.
-
Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US Hospitals. JAMA Netw Open. 2019 07 03; 2(7):e196476.
-
A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents. Am J Hematol. 2019 01; 94(1):74-79.
-
Cost-effectiveness and Improved Parent and Provider Satisfaction With Outpatient Management of Pediatric Oncology Patients, With Low-risk Fever and Neutropenia. J Pediatr Hematol Oncol. 2018 10; 40(7):e415-e420.
-
Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption. Pediatr Dermatol. 2018 Jan; 35(1):e86-e87.
-
Protocol for Reducing Time to Antibiotics in Pediatric Patients Presenting to an Emergency Department With Fever and Neutropenia: Efficacy and Barriers. Pediatr Emerg Care. 2016 Nov; 32(11):739-745.
-
The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis. Breast Cancer Res Treat. 2015 Oct; 153(3):591-7.